Stock Doctor

Call Directions Website Contact the business

Stock Doctor Stock Doctor is Australia’s leading DIY stock research and portfolio platform, built on Dr Merv Lincoln’s proven investment methodology. Growth Fund.

Get independent insights, expert recommendations, and powerful tools. Explore more: https://www.stockdoctor.com.au/ At Lincoln Indicators, we invest in facts, not opinions. We offer investors the option to invest in stocks themselves with Stock Doctor - one of Australia’s premier stock research, ratings and insights tool with portfolio tracker and manager features too. For investors who want us to manage their investments, we do it for them through our Managed Funds: Australian Income Fund, Australian Growth Fund and U.S. We help investors invest in the numbers with confidence, control and peace of mind.

12/10/2026

This week on Taking Stock, Jason Yin and Charlie Song examine the surge in US bond yields despite record equity markets, and what higher interest rates in the US and Australia could mean for growth-stock valuations.

They review Capricorn Metals' (CMM) production update, explore CSL's (CSL) US$355 million licensing deal with Alentis Therapeutics and lift the hood on Cochlear (COH) which faces a new competitive threat from MED-EL.

Finally, the pair discuss how investors can assess disruption risk and determine whether competitive threats are already reflected in share prices.

Watch the latest episode :https://www.stockdoctor.com.au/insights-and-events/taking-stock-weekly-insights-9-october-2026

When you manage your own super, the decisions are yours, but they don’t have to be made without insight.Quality research...
01/10/2026

When you manage your own super, the decisions are yours, but they don’t have to be made without insight.

Quality research can provide valuable context when assessing opportunities, reviewing investments and making considered portfolio decisions.

Our latest article, The Informed SMSF Investor: Why Research Matters, explores how research can support a more informed and structured approach to your investment journey.

Discover the key considerations in our latest article:https://www.stockdoctor.com.au/insights-and-events/the-informed-smsf-investor-why-research-matters

21/09/2026

This week on Taking Stock, Kien Trinh and Matt Swartz unpack rising inflation and interest rate pressures.

They assess the AI opportunity at wealth platform Netwealth (ASX:NWL) and the regulatory setback facing medical AI developer Echo IQ (ASX:EIQ).

They also put building products giant James Hardie (ASX:JHX) under the microscope following its trading update, and explore which sectors are better positioned in a higher-inflation, rising-rate environment.

Watch the latest episode today :https://www.stockdoctor.com.au/insights-and-events/taking-stock-weekly-insights-18-september-2026

15/09/2026

This week on Taking Stock, Jason Yin and Charlie Song unpack the surge in oil prices above US$100 a barrel and the global bond-market sell-off, before considering what higher interest-rate expectations could mean for equities, risk assets and gold.

They review Sigma Healthcare’s (ASX:SIG) strong FY26 result, assess the consumer outlook through JB Hi-Fi (ASX:JBH), Universal Store (ASX:UNI) and Lovisa (ASX:LOV), and put Mader Group (ASX:MAD) under the microscope.

They also explain why a high-quality company can become less attractive when its valuation leaves little room for disappointment.

Watch the latest episode today: https://www.stockdoctor.com.au/insights-and-events/taking-stock-weekly-insights-11-september-2026

Reporting season provides valuable insights into company performance, but understanding the broader themes is equally im...
10/09/2026

Reporting season provides valuable insights into company performance, but understanding the broader themes is equally important.

As investors assess the latest results, attention is turning to the trends, signals and commentary influencing market sentiment.

Join Kien Trinh and Mathew Potts as they discuss the key developments emerging from reporting season, including company results, sector trends and the factors shaping today's market environment.

Register today: https://www.stockdoctor.com.au/resource/reporting-season-looking-beyond-the-numbers

07/09/2026

This week on Taking Stock, Kien Trinh and Jason Yin unpack the key lessons from reporting season and where opportunities are emerging after recent volatility.

They examine investment manager Pinnacle (ASX:PNI) amid growing scrutiny of its private credit affiliate Metrics.

They also highlight where income and growth investors can find opportunities heading into FY27.

Watch the latest episode today: https://www.stockdoctor.com.au/insights-and-events/taking-stock-weekly-insights-4-september-2026

Strong stories don't always translate into strong investments.Revenue growth and positive headlines can capture investor...
03/09/2026

Strong stories don't always translate into strong investments.

Revenue growth and positive headlines can capture investor attention, but Financial Health often reveals a deeper picture of business quality and resilience.

At Stock Doctor, Financial Health remains the first step in our investment process because understanding what's happening beneath the surface can be just as important as understanding the growth story.

Explore the full article: https://www.stockdoctor.com.au/insights-and-events/what-every-quality-company-has-in-common

31/08/2026

This week on Taking Stock, Kien Trinh and Charlie Song unpack softer FY27 earnings expectations and contrasting reporting-season reactions across retail, telcos and industrials.

They assess results from retail giants Wesfarmers (ASX:WES) and Lovisa (ASX:LOV), revisit the outlook for telecommunications leader Telstra (ASX:TLS) and engineering contractor Monadelphous (ASX:MND), and put global pallet-pooling provider Brambles (ASX:BXB) under the microscope.

They also explain how to easily track Star Stock updates and recommendation changes.

Watch the latest episode today: https://www.stockdoctor.com.au/insights-and-events/taking-stock-weekly-insights-28-august-2026

Wesfarmer FY26 result highlighted the challenges of meeting high investor expectations, with earnings growth across the ...
28/08/2026

Wesfarmer FY26 result highlighted the challenges of meeting high investor expectations, with earnings growth across the portfolio overshadowed by concerns around future growth and increasing investment costs.

From continued earnings growth at Bunnings and Kmart to strong contributions from Health and WesCEF, the result showcased the benefits of a diversified earnings base.

However, softer growth expectations across key divisions and rising capital expenditure became the primary focus for investors.

Join our upcoming Reporting Season Webinar as our analysts unpack the key opportunities, risks and trends emerging from this reporting season's results.

Register today to reserve your place: https://www.stockdoctor.com.au/resource/reporting-season-looking-beyond-the-numbers

Qantas' FY26 result highlighted the ongoing importance of travel demand, Loyalty earnings and fleet renewal, while also ...
28/08/2026

Qantas' FY26 result highlighted the ongoing importance of travel demand, Loyalty earnings and fleet renewal, while also demonstrating the impact higher fuel costs can have on profitability.

From growing revenue and double-digit Loyalty earnings growth to rising operating costs and increased investment in the business, Qantas' latest result provided several key insights for investors.

Join our upcoming Reporting Season Webinar as our analysts unpack the key opportunities, risks and trends emerging from this reporting season's results.

Register today to reserve your place: https://www.stockdoctor.com.au/resource/reporting-season-looking-beyond-the-numbers

Address

HWT Tower, Level 17, 40 City Road, Southbank
Melbourne, VIC
3006

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Telephone

1300 676 333

Website

Alerts

Be the first to know and let us send you an email when Stock Doctor posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Stock Doctor:

Shortcuts

Sponsored

Share

Category